1. Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patients. (December 2019) Authors: Martell, K.; Mendez, L.C.; Chung, H.T.; Tseng, C.L.; Alayed, Y.; Cheung, P.; Liu, S.; Vesprini, D.; Chu, W.; Wronski, M.; Szumacher, E.; Ravi, A.; Loblaw, A.; Morton, G. Journal: Radiotherapy and oncology Issue: Volume 141(2019) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Absolute percentage of biopsied tissue positive for Gleason pattern 4 disease (APP4) appears predictive of disease control after high dose rate brachytherapy and external beam radiotherapy in intermediate risk prostate cancer. (June 2019) Authors: Martell, K.; Mendez, L.C.; Chung, H.; Tseng, C.L.; Zhang, L.; Alayed, Y.; Liu, S.; Vesprini, D.; Chu, W.; Paudel, M.; Cheung, P.; Szumacher, E.; Ravi, A.; Loblaw, A.; Morton, G. Journal: Radiotherapy and oncology Issue: Volume 135(2019) Page Start: 170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1408 Two-fraction prostate SABR vs. two-fraction HDR brachytherapy: does dose heterogeneity matter?. (May 2022) Authors: Correa, R.; Morton, G.; Chung, H.; Tseng, C.; Cheung, P.; Chu, W.; Liu, S.; McGuffin, M.; Shahid, A.; Davidson, M.; Ravi, A.; Helou, J.; Alayed, Y.; Zhang, L.; Mamedov, A.; Loblaw, A. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-0840 Two StereoTactic Ablative Radiotherapy Treatments for Localized Prostate Cancer (2STAR). (April 2019) Authors: Alayed, Y.; Cheung, P.; Chu, W.; Chung, H.; Davidson, M.; Ravi, A.; Helou, J.; Zhang, L.; Mamedov, A.; Commisso, A.; Commisso, K.; Loblaw, A. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC-0288 Long-term results of 15Gy HDRBT boost in intermediate risk-prostate cancer:Analysis of 500 + patients. (April 2019) Authors: Mendez, L.; Martell, K.; Chung, H.; Tseng, C.; Alayed, Y.; Cheung, P.; Liu, S.; Vesprini, D.; Chu, W.; Szumacher, E.; Ravi, A.; Loblaw, A.; Morton, G. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗